description | REBYOTA® is the 1st and only single-dose, FDA-approved microbiome-based therapy to keep recurrent C. diff infection from coming back, after antibiotics. |
introduction |
www.rebyota.com There are 4 links were found on the page. There are 3 backlinks link to www.rebyota.com There are 1 anchor text link to www.rebyota.com,the most used anchor text in all backlinks is: REBYOTA™ (fecal microbiota, live – jslm) suspension for rectal use |
update time | 2025-06-07 09:35:33 |
type: text
text: For Healthcare Professionals
link: www.rebyotahcp.com
behavior: follow
type: picture
alt: Ferring Pharmaceuticals logo
link: ferringusa.com
behavior: follow
type: text
text: SpeedBump Excluded URL
link: survey.viewpointforum.com
behavior: follow
type: text
text: SpeedBump Excluded URL
link: ferringusa.ethicspointvp.com
behavior: follow
site: ferringusa.com
type: text
text: REBYOTA™ (fecal microbiota, live – jslm) suspension for rectal use
link: www.rebyota.com
behavior: follow
site: www.ferring-research.com
type: text
text: REBYOTA™ (fecal microbiota, live – jslm) suspension for rectal use
link: www.rebyota.com
behavior: follow
site: www.ferringusa.com
type: text
text: REBYOTA™ (fecal microbiota, live – jslm) suspension for rectal use
link: www.rebyota.com
behavior: follow